Cost-Utility Analysis of Lisdexamfetamine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in the United Kingdom

Zimovetz, E., Beard, S., Hodgkins, P., Bischof, M., Mauskopf, J., & Setyawan, J. (2013). Cost-Utility Analysis of Lisdexamfetamine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in the United Kingdom. Value in Health, 16(7), A549-A549.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

OCCASIONAL PAPER

The Preschool Entitlement
OCCASIONAL PAPER

Culturally informed community engagement
Article

Does the relationship between alcohol retail environment and alcohol outcomes vary by depressive symptoms? Findings from a US Survey of Black, Hispanic and White drinkers
Article

Far-right and Jihadi terrorism within the United States